Honest, editorial writing on psychedelic-assisted therapy — the science, the safety, and the human stories behind life-changing decisions.
Evidence-led reporting on ibogaine and psychedelic treatment: what the research shows, what the news means for patients, how to choose and prepare, and honest comparisons between treatments. Every article is clinically reviewed, cites its sources in-frame and says plainly what remains unproven.
In a 2024 Stanford study published in Nature Medicine, ibogaine was associated with roughly an 88% reduction in PTSD symptoms among 30 special-operations veterans with traumatic brain injury — with no serious safety events. Here's what it found, and what it means.
The pilot that put ibogaine on the world's front pages.
Read →How federal moves are shifting research & access.
Read →What the data does — and doesn't — yet show.
Read →Phase-3 momentum on the path to approval.
Read →The 2024 decision, and what comes next.
Read →What the trials show about rapid relief.
Read →A country-by-country status check.
Read →How these medicines reset the brain.
Read →What proper cardiac screening looks like.
Read →The green flags and the red flags.
Read →Inside the ten-dimension Provider Standard™.
Read →Medical, emotional & practical readiness.
Read →A copyable checklist you can bring.
Read →Where the results are kept — or lost.
Read →Warning signs of an unsafe program.
Read →Trauma, moral injury and TBI — and real relief.
Read →What the research and real stories say.
Read →The newer dependence ibogaine can address.
Read →Ketamine, psilocybin, and what's next.
Read →A circuit-breaker for long-standing drinking.
Read →Healing what sits underneath.
Read →Quieting a mind that won't stop bracing.
Read →How it can switch off physical withdrawal.
Read →Onset, peak, the purge, the afterglow — plainly.
Read →Two very different medicines.
Read →Accessible now vs. the deeper reset.
Read →Interrupting addiction vs. shifting depression.
Read →Two roads to the same wound.
Read →Which setting suits whom.
Read →What holds, and what needs upkeep.
Read →When you're ready, a real advisor can turn all of this into a clear, safe next step — confidential, and guided by people who get it.
Weekly, with dated publish and last-updated lines on every article.
Christopher Diviaio, LCSW, our named clinical reviewer.
Yes — send it through the consultation page.
